Clinical Trial

Long-term Observational Study to Evaluate the DFS and OS of Adjuvant FOLFIRINOX Regimen in Pancreatic Cancer Patients

Recruiting
View on ClinicalTrials.gov →
Summary
This study is designed to evaluate the safety and efficacy of adjuvant FOLFIRINOX regimen in pancreatic cancer patients after curative surgery.
Trial Details
NCT Number NCT06389552
Lead Sponsor HK inno.N Corporation
Conditions Adjuvant Chemotherapy
Enrollment 36 participants
Start Date 2023-09-25
Primary Completion 2026-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2024-04-29